PL1684775T3 - Zastosowanie wyciągów z roślin rodzaju pelargonium - Google Patents

Zastosowanie wyciągów z roślin rodzaju pelargonium

Info

Publication number
PL1684775T3
PL1684775T3 PL04790852T PL04790852T PL1684775T3 PL 1684775 T3 PL1684775 T3 PL 1684775T3 PL 04790852 T PL04790852 T PL 04790852T PL 04790852 T PL04790852 T PL 04790852T PL 1684775 T3 PL1684775 T3 PL 1684775T3
Authority
PL
Poland
Prior art keywords
lps
seconds
treatment
gen
mice
Prior art date
Application number
PL04790852T
Other languages
English (en)
Inventor
Shyam Sunder Chatterjee
Egon Koch
Michael Nöldner
Original Assignee
Dr Willmar Schwabe Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34258760&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1684775(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dr Willmar Schwabe Gmbh & Co Kg filed Critical Dr Willmar Schwabe Gmbh & Co Kg
Publication of PL1684775T3 publication Critical patent/PL1684775T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
PL04790852T 2003-10-29 2004-10-26 Zastosowanie wyciągów z roślin rodzaju pelargonium PL1684775T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10350338A DE10350338B3 (de) 2003-10-29 2003-10-29 Verwendung von Extrakten aus Pelargonium Spezies
PCT/EP2004/012069 WO2005041993A1 (de) 2003-10-29 2004-10-26 Verwendung von extrakten aus pelargonium-spezies
EP04790852A EP1684775B1 (de) 2003-10-29 2004-10-26 Verwendung von extrakten aus pelargonium-spezies

Publications (1)

Publication Number Publication Date
PL1684775T3 true PL1684775T3 (pl) 2008-09-30

Family

ID=34258760

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04790852T PL1684775T3 (pl) 2003-10-29 2004-10-26 Zastosowanie wyciągów z roślin rodzaju pelargonium

Country Status (18)

Country Link
US (1) US7611734B2 (pl)
EP (1) EP1684775B1 (pl)
JP (1) JP2007509876A (pl)
KR (1) KR20060127839A (pl)
CN (1) CN1852723A (pl)
AT (1) ATE390143T1 (pl)
AU (1) AU2004285273B2 (pl)
BR (1) BRPI0415868A (pl)
CA (1) CA2540891A1 (pl)
DE (2) DE10350338B3 (pl)
DK (1) DK1684775T3 (pl)
ES (1) ES2299877T3 (pl)
MX (1) MXPA06003744A (pl)
PL (1) PL1684775T3 (pl)
PT (1) PT1684775E (pl)
RU (1) RU2342941C2 (pl)
UA (1) UA82381C2 (pl)
WO (1) WO2005041993A1 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004032439A1 (de) * 2004-07-05 2006-02-02 Iso Arzneimittel Gmbh & Co Kg Verwendung von Extrakten aus Wurzeln von Pelargonium sidoides und Pelargonium reniforme
WO2008125239A2 (de) * 2007-04-17 2008-10-23 Dr. Willmar Schwabe Gmbh & Co. Kg Trockenextrakte aus pelargonium sidoides und pelargonium reniforme
KR100896453B1 (ko) * 2007-07-18 2009-05-14 닥터 빌마르 쉬바베 게엠바하 운트 코 카게 페라고늄 시도이데스 시럽
EP2908833B1 (en) * 2012-10-17 2017-04-26 Montero Gida Sanayi Ve Ticaret A.S. Formulations comprising herbal extracts
PT2908835T (pt) * 2012-10-18 2017-07-19 Montero Gida Sanayi Ve Ticaret As Formulações estáveis
IT201800002457A1 (it) * 2018-02-07 2019-08-07 Neilos S R L Composizione per la prevenzione e il trattamento delle affezioni delle vie respiratorie
KR102207603B1 (ko) * 2019-07-02 2021-01-26 동의대학교 산학협력단 로즈제라늄 정유를 포함하는 수면 유도용 조성물
KR102244814B1 (ko) * 2019-07-17 2021-04-26 동의대학교 산학협력단 로즈제라늄 정유를 포함하는 스트레스 완화용 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4429735C2 (de) * 1994-08-22 1996-10-02 Mepat Ltd Pflanzlicher Redoxkatalysator, Mittel zur Behandlung immunbiologischer Zellbelastungsschwächen und Verfahren zu dessen Herstellung
GB2355189B (en) * 1999-08-20 2004-07-28 Yousef Haik Babikian Herbal preparation for the treatment of diabetes mellitus
US7128924B2 (en) * 2001-02-12 2006-10-31 Council Of Scientific & Industrial Research Safe, eco-friendly, health protective herbal colors and aroma useful for cosmaceutical applications
DK1429795T3 (da) * 2001-09-27 2007-10-01 Schwabe Willmar Gmbh & Co Fremgangsmåde til fremstilling af ekstrakter af Pelargonium sidoides og/eller Pelargonium reniforme
GB2381195A (en) * 2002-07-12 2003-04-30 Clare G Harvey Orchid essence containing medicaments for the treatment of stress

Also Published As

Publication number Publication date
US20070014877A1 (en) 2007-01-18
CA2540891A1 (en) 2005-05-12
AU2004285273B2 (en) 2009-11-12
CN1852723A (zh) 2006-10-25
PT1684775E (pt) 2008-04-23
JP2007509876A (ja) 2007-04-19
UA82381C2 (uk) 2008-04-10
DK1684775T3 (da) 2008-06-16
EP1684775A1 (de) 2006-08-02
ATE390143T1 (de) 2008-04-15
AU2004285273A1 (en) 2005-05-12
US7611734B2 (en) 2009-11-03
DE10350338B3 (de) 2005-04-07
RU2006108398A (ru) 2007-09-27
BRPI0415868A (pt) 2007-01-09
RU2342941C2 (ru) 2009-01-10
ES2299877T3 (es) 2008-06-01
WO2005041993A1 (de) 2005-05-12
KR20060127839A (ko) 2006-12-13
MXPA06003744A (es) 2006-06-14
EP1684775B1 (de) 2008-03-26
DE502004006688D1 (de) 2008-05-08

Similar Documents

Publication Publication Date Title
PT1684775E (pt) Utilização de extractos feitos de espécies de pelargonium
Boyce et al. Differential effects of D1 and D2 agonists in MPTP‐treated primates: functional implications for Parkinson's disease
Ferré et al. Postsynaptic dopamine/adenosine interaction: I. Adenosine analogues inhibit dopamine D2-mediated behaviour in short-term reserpinized mice
Biney et al. Xylopia aethiopica fruit extract exhibits antidepressant-like effect via interaction with serotonergic neurotransmission in mice
Tuma et al. Anxiolytic-like action of the antidepressant agomelatine (S 20098) after a social defeat requires the integrity of the SCN
NO20075344L (no) Metforminbaserte fremgangsmater og utforminger for behandling av kronisk forstoppelse
ES2245944T3 (es) Uso de composiciones para tratar o prevenir alteraciones del sueño utilizando dosis muy bajas de ciclobenzaprina.
Woode et al. An evaluation of the anti-inflammatory, antipyretic and antinociceptive effects of Ficus exasperata (Vahl) leaf extract
JP2020514285A (ja) 龍眼肉抽出物を含有する二日酔い予防または解消用組成物
Desole et al. Effects of morphine treatment and withdrawal on striatal and limbic monoaminergic activity and ascorbic acid oxidation in the rat
Baranwal et al. Anti-arthritic activity of some indigenous plants: a review
Ögren et al. Anti‐aggressive effect of zimelidine in isolated mice
KR20020073847A (ko) 쿠르쿠민 또는 울금 추출물을 포함하는 치매 예방 및치료용 조성물
Marsden et al. The role of tryptamine in the behavioural effects of tranylcypromine+ L-tryptophan
Amos et al. Evaluation of methanolic extract of Ficus platyphylla on gastrointestinal activity
Baggio et al. Role of brain dopaminergic mechanisms in rodent aggressive behavior: Influence of (±) Nn-propyl-norapomorphine on three experimental models
Abe et al. γ-Acid Metabolism in Subcellular Particles of Mouse Brain and Its Relationship to Convulsions
Worms et al. The behavioural effects of systemically administered kainic acid: a pharmacological analysis
Ohmura et al. 5-Hydroxytryptophan attenuates somatic signs of nicotine withdrawal
Hansard et al. Dopamine reuptake inhibition and failure to evoke dyskinesia in MPTP-treated primates
Calabrese 5-Hydroxytryptamine (serotonin): biphasic dose responses
JP2019517468A (ja) 付加的抗うつ剤組成物及びその使用方法
Levine et al. Effects of neonatal and adult 6-hydroxydopamine treatment on random-interval behavior
EA200400386A1 (ru) Фармацевтическая композиция, содержащая гамма-бутиробетаин
Ganu et al. Anticonvulsant activity of a Mimusops elengi in experimental animals